AMENDMENT TO LICENSE AGREEMENTSLicense Agreements • May 7th, 2009 • Immunogen Inc • Pharmaceutical preparations • New York
This Amendment to License Agreements (the “Amendment”) is made effective as of the date of the last signature below (the “Amendment Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (“ImmunoGen”), having its principal business office at 830 Winter Street, Waltham, Massachusetts 02451, and Genentech, Inc., a Delaware corporation (“Genentech”), having its principal business office at 1 DNA Way, South San Francisco, California 94080. ImmunoGen and Genentech are herein sometimes referred to as a “Party” and collectively as the “Parties.”
